ReviewPolymers2025
Abiotic Degradation Technologies to Promote Bio-Valorization of Bioplastics.
Review in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Influence of PLA Flowability and Talc Content on the Performance of Rigid TPS/PBS/PLA/Talc Blends.Polymers · 2026Article
- Hydrothermal fenton oxidation for sustainable degradation of bioplastics, PLA, PBAT, PHA, and PBS.Scientific reports · 2026Article
- Recycling and Degradation of Polymeric Materials: Exploring Different Perspectives in Plastic Waste Management.Materials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Biodegradable bioplastics have emerged as a promising sustainable alternative to minimize the environmental impact of traditional plastics. Nevertheless, many of them degrade slowly under natural or industrial conditions, raising concerns about their practical biodegradability. This fact is related to the high-order structure of the polymer backbones, i.e., high molar mass and high crystallinity. Research efforts are being devoted to the development of technologies capable of reducing the length of polymer segments by accelerated chain scission, which could help improve biodegradation rates upon disposal of bioplastic products. The objective of this review is to examine the current state of the art of abiotic degradation techniques, physically driven by temperature, mechanical stress, UV/gamma/microwave irradiation, or plasma or dielectric barrier discharge, and chemically induced by ozone, water, or acidic/basic solutions, with the aim of enhancing the subsequent biodegradation of bioplastics in controlled valorization scenarios such as composting and anaerobic digestors. Particular attention is given to pretreatment degradation technologies that modify surface properties to enhance microbial adhesion and enzymatic activity. Technologies such as ozonation and plasma-driven treatments increase surface hydrophilicity and introduce functional groups with oxygen bonds, facilitating subsequent microbial colonization and biodegradation. Irradiation-based techniques directly alter the chemical bonds at the polymer surface, promoting the formation of free radicals, chain scission, and crosslinking, thereby modifying the polymer structure. Pretreatments involving immersion in aqueous solutions may induce solution sorption and diffusion, together with hydrolytic chain breakage in bulk, with a relevant contribution to the ulterior biodegradation performance. By promoting abiotic degradation and increasing the accessibility of biopolymers to microbial systems, these pretreatment strategies can offer effective tools to enhance biodegradation and, therefore, the end-of-life management of bioplastics, supporting the transition toward sustainable cradle-to-cradle pathways within a biocircular economy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.